Paroxysmal Nocturnal Hemoglobinuria (PNH)

Maxim Norkin, MD, PhD, is board certified in hematology and oncology with clinical expertise in hematological malignancies and bone marrow transplantation. An advisory group member of the National Marrow Donor Program, Dr. Norkin has served as a principal investigator on multiple clinical trials and is dedicated to providing the best evidenced-based care to his patients.

Dr. Luskin received her MD from the University of Pennsylvania Perelman School of Medicine in 2009. She completed residency training in Internal Medicine at Brigham and Women's Hospital, followed by a fellowship in Hematology and Oncology at the University of Pennsylvania. She joined Dana-Farber as a member of the Adult Leukemia program in 2016.

Melhem Solh, M.D., is board certified in the subspecialties of medical oncology and hematology. Dr. Solh is a Northside Hospital Blood and Marrow Transplant and Leukemia Program physician.In 2019, Dr. Solh was recognized as among Atlanta’s Top Doctors in his specialty by Castle Connolly.

As a physician–scientist, Dr. Tibes is grateful for the opportunity to advance treatments for people who have cancer through my own groundbreaking research. He has been involved in developing national treatment guidelines for leukemia, and he has been actively engaged in translational research to identify and develop new leukemia treatments over the last few years. Many of these treatments, which directly target the DNA of cancer cells or push leukemia cells to die, were developed in Dr. Tibes' laboratory and have led to clinical trials and U.S. Food and Drug Administration approvals. In his